Goldman Sachs Group Inc. cut its position in shares of Stem, Inc. (NYSE:STEM - Free Report) by 35.9% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 392,181 shares of the company's stock after selling 219,715 shares during the period. Goldman Sachs Group Inc. owned about 4.71% of Stem worth $137,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of STEM. AQR Capital Management LLC increased its position in shares of Stem by 505.8% during the first quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company's stock valued at $519,000 after purchasing an additional 1,238,012 shares during the period. Cerity Partners LLC bought a new stake in Stem in the first quarter valued at $29,000. Charles Schwab Investment Management Inc. grew its position in Stem by 22.0% in the first quarter. Charles Schwab Investment Management Inc. now owns 444,053 shares of the company's stock valued at $156,000 after acquiring an additional 80,000 shares during the period. CWM LLC grew its position in Stem by 317.7% in the first quarter. CWM LLC now owns 89,913 shares of the company's stock valued at $31,000 after acquiring an additional 68,386 shares during the period. Finally, Hsbc Holdings PLC grew its position in Stem by 5.6% in the first quarter. Hsbc Holdings PLC now owns 873,282 shares of the company's stock valued at $307,000 after acquiring an additional 46,573 shares during the period. 61.63% of the stock is currently owned by institutional investors.
Stem Stock Down 3.7%
Shares of STEM opened at $17.20 on Tuesday. Stem, Inc. has a 12-month low of $5.81 and a 12-month high of $33.60. The firm has a market capitalization of $144.34 million, a PE ratio of -0.59 and a beta of 1.32. The stock's fifty day simple moving average is $15.39 and its 200-day simple moving average is $11.15.
Stem (NYSE:STEM - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($3.73) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.00) by ($0.73). The firm had revenue of $38.40 million during the quarter, compared to analyst estimates of $32.18 million. Stem has set its FY 2025 guidance at EPS. Analysts anticipate that Stem, Inc. will post -0.52 EPS for the current year.
Analyst Ratings Changes
A number of brokerages have weighed in on STEM. Barclays set a $13.00 price target on Stem and gave the company an "equal weight" rating in a research report on Monday, August 11th. UBS Group upped their price target on Stem from $8.60 to $16.00 and gave the company a "neutral" rating in a research report on Friday, August 22nd. Seven analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $10.86.
Check Out Our Latest Analysis on STEM
Stem Profile
(
Free Report)
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
Recommended Stories
Want to see what other hedge funds are holding STEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stem, Inc. (NYSE:STEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stem wasn't on the list.
While Stem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.